Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 6, 2015, Pages 1374-1381

  Kuijpers, Marijke J E ^a   Mattheij, Nadine J A ^a   Cipolla, Lina ^b   Van Geffen, Johanna P ^a   Lawrence, Toby ^c   Donners, Marjo M P C ^a   Boon, Louis ^d   Lievens, Dirk ^a   Torti, Mauro ^b   Noels, Heidi ^f   Gerdes, Norbert ^e   Cosemans, Judith M E M ^a   Lutgens, Esther ^e,g   Heemskerk, Johan W M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF PAVIA   (Italy)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^d BIOCEROS   (Netherlands)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f RWTH AACHEN UNIVERSITY   (Germany)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

atherosclerosis; atherothrombosis; blood platelets; CD40; CD40 ligand; signal transduction; signaling pathways; thrombosis

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; COLLAGEN; CONVULXIN; GLYCOPROTEIN VI; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE BETA; THROMBIN; UNCLASSIFIED DRUG; I KAPPA B KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS; THROMBUS; ANIMAL; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD40; ATHEROSCLEROSIS; BLOOD PLATELETS; CD40 LIGAND; COLLAGEN; I-KAPPA B KINASE; MICE; PHOSPHATIDYLINOSITOL 3-KINASE; PLATELET ACTIVATION; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 84933042246     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.305127     Document Type: Article

References (46)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234. doi: 10.1038/nm1102-1227.
2. Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW. Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis. 2005;181:19-27. doi: 10.1016/j. atherosclerosis.2004.12.037.
3. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J. 2005;19:898-909. doi: 10.1096/fj.04-2748com.
4. Kuijpers MJ, Gilio K, Reitsma S, Nergiz-Unal R, Prinzen L, Heeneman S, Lutgens E, van Zandvoort MA, Nieswandt B, Egbrink MG, Heemskerk JW. Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model. J Thromb Haemost. 2009;7:152-161. doi: 10.1111/j.1538-7836.2008.03186.x.
5. Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93:327-358. doi: 10.1152/physrev.00016.2011.
6. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res. 2003;92:1041-1048. doi: 10.1161/01. RES.0000070111.98158.6C.
7. Gavins FN, Li G, Russell J, Perretti M, Granger DN. Microvascular thrombosis and CD40/CD40L signaling. J Thromb Haemost. 2011;9:574-581. doi: 10.1111/j.1538-7836.2010.04176.x.
8. Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120:e73-e82. doi: 10.1182/blood-2012-04-416594.
9. Choi WS, Jeon OH, Kim DS. CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha(IIb)beta(3). J Thromb Haemost. 2010;8:1364-1371. doi: 10.1111/j.1538-7836.2010.03837.x.
10. Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. J Thromb Haemost. 2013;11:1385-1398. doi: 10.1111/jth.12273.
11. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 2003;108:1049-1052. doi: 10.1161/01.CIR.0000088521.04017.13.
12. Tousoulis D, Androulakis E, Papageorgiou N, Briasoulis A, Siasos G, Antoniades C, Stefanadis C. From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand. Trends Cardiovasc Med. 2010;20:153-164. doi: 10.1016/j.tcm.2010.12.004.
13. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998;394:200-203. doi: 10.1038/28204.
14. Lutgens E, Lievens D, Beckers L, et al. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med. 2010;207:391-404. doi: 10.1084/jem.20091293.
15. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA. Requirement for CD154 in the progression of atherosclerosis. Nat Med. 1999;5:1313-1316. doi: 10.1038/15271.
16. Donners MM, Beckers L, Lievens D, et al. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood. 2008;111:4596-4604. doi: 10.1182/blood-2007-05-088906.
17. Lievens D, Zernecke A, Seijkens T, et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood. 2010;116:4317-4327. doi: 10.1182/blood-2010-01-261206.
18. Yacoub D, Hachem A, Théorêt JF, Gillis MA, Mourad W, Merhi Y. Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2/Rac1/p38 mitogen-activated protein kinase signaling pathway. Arterioscler Thromb Vasc Biol. 2010;30:2424-2433. doi: 10.1161/ATVBAHA.110.216143.
19. Hachem A, Yacoub D, Zaid Y, Mourad W, Merhi Y. Involvement of nuclear factor ?B in platelet CD40 signaling. Biochem Biophys Res Commun. 2012;425:58-63. doi: 10.1016/j.bbrc.2012.07.049.
20. Malaver E, Romaniuk MA, D'Atri LP, Pozner RG, Negrotto S, Benzadón R, Schattner M. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost. 2009;7:1333-1343. doi: 10.1111/j.1538-7836.2009.03492.x.
21. André P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med. 2002;8:247-252. doi: 10.1038/nm0302-247.
22. Prasad KS, Andre P, He M, Bao M, Manganello J, Phillips DR. Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proc Natl Acad Sci U S A. 2003;100:12367-12371. doi: 10.1073/pnas.2032886100.
23. Nergiz-Unal R, Cosemans JM, Feijge MA, van der Meijden PE, Storey RF, van Giezen JJ, oude Egbrink MG, Heemskerk JW, Kuijpers MJ. Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaques. PLoS One. 2010;5:e10130. doi: 10.1371/journal.pone.0010130.
24. Siljander P, Farndale RW, Feijge MA, Comfurius P, Kos S, Bevers EM, Heemskerk JW. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain. Arterioscler Thromb Vasc Biol. 2001;21:618-627.
25. Kuijpers MJ, de Witt S, Nergiz-Unal R, van Kruchten R, Korporaal SJ, Verhamme P, Febbraio M, Tjwa M, Voshol PJ, Hoylaerts MF, Cosemans JM, Heemskerk JW. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen. Arterioscler Thromb Vasc Biol. 2014;34:1187-1192. doi: 10.1161/ATVBAHA.113.302917.
26. Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118:e101-e111. doi: 10.1182/blood-2011-03-339705.
27. Jackson SP, Schoenwaelder SM, Goncalves I, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med. 2005;11:507-514. doi: 10.1038/nm1232.
28. Gibbins JM. Platelet adhesion signalling and the regulation of thrombus formation. J Cell Sci. 2004;117:3415-3425. doi: 10.1242/jcs.01325.
29. Gratacap MP, Guillermet-Guibert J, Martin V, Chicanne G, Tronchère H, Gaits-Iacovoni F, Payrastre B. Regulation and roles of PI3K?, a major actor in platelet signaling and functions. Adv Enzyme Regul. 2011;51:106-116. doi: 10.1016/j.advenzreg.2010.09.011.
30. Canobbio I, Stefanini L, Cipolla L, Ciraolo E, Gruppi C, Balduini C, Hirsch E, Torti M. Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM-and integrin-mediated signaling in platelets. Blood. 2009;114:2193-2196. doi: 10.1182/blood-2009-03-208074.
31. Martin V, Guillermet-Guibert J, Chicanne G, Cabou C, Jandrot-Perrus M, Plantavid M, Vanhaesebroeck B, Payrastre B, Gratacap MP. Deletion of the p110beta isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo. Blood. 2010;115:2008-2013. doi: 10.1182/blood-2009-04-217224.
32. Lee HS, Kim SD, Lee WM, Endale M, Kamruzzaman SM, Oh WJ, Cho JY, Kim SK, Cho HJ, Park HJ, Rhee MH. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations. Eur J Pharmacol. 2010;627:85-91. doi: 10.1016/j.ejphar.2009.11.005.
33. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-?B signaling pathways. Nat Immunol. 2011;12:695-708. doi: 10.1038/ni.2065.
34. Sun SC. Non-canonical NF-?B signaling pathway. Cell Res. 2011;21:71-85. doi: 10.1038/cr.2010.177.
35. Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV, Karin M. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell. 2001;107:763-775.
36. Law CL, Gewal IS. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. In:Grewal IS, ed. Therapeutics of the TNF Superfamily. Berlin, Germany: Landes Biosciences and Springer 2009:8-36
37. Chakrabarti S, Blair P, Freedman JE. CD40-40L signaling in vascular inflammation. J Biol Chem. 2007;282:18307-18317. doi: 10.1074/jbc. M700211200.
38. Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E. The multifunctionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost. 2009;102:206-214. doi: 10.1160/TH09-01-0029.
39. Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fässler R. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 2001;20:2120-2130. doi: 10.1093/emboj/20.9.2120.
40. Kuijpers MJ, Schulte V, Bergmeier W, Lindhout T, Brakebusch C, Offermanns S, Fässler R, Heemskerk JW, Nieswandt B. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo. FASEB J. 2003;17:685-687. doi: 10.1096/fj.02-0381fje.
41. Gilio K, Munnix IC, Mangin P, Cosemans JM, Feijge MA, van der Meijden PE, Olieslagers S, Chrzanowska-Wodnicka MB, Lillian R, Schoenwaelder S, Koyasu S, Sage SO, Jackson SP, Heemskerk JW. Nonredundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J Biol Chem. 2009;284:33750-33762. doi: 10.1074/jbc.M109.048439.
42. Schoenwaelder SM, Ono A, Nesbitt WS, Lim J, Jarman K, Jackson SP. Phosphoinositide 3-kinase p110 beta regulates integrin alpha IIb beta 3 avidity and the cellular transmission of contractile forces. J Biol Chem. 2010;285:2886-2896. doi: 10.1074/jbc.M109.029132.
43. Consonni A, Cipolla L, Guidetti G, Canobbio I, Ciraolo E, Hirsch E, Falasca M, Okigaki M, Balduini C, Torti M. Role and regulation of phosphatidylinositol 3-kinase ? in platelet integrin ?2?1 signaling. Blood. 2012;119:847-856. doi: 10.1182/blood-2011-07-364992.
44. Karim ZA, Zhang J, Banerjee M, Chicka MC, Al Hawas R, Hamilton TR, Roche PA, Whiteheart SW. I?B kinase phosphorylation of SNAP-23 controls platelet secretion. Blood. 2013;121:4567-4574. doi: 10.1182/blood-2012-11-470468.
45. Wei S, Wang H, Zhang G, Lu Y, An X, Ren S, Wang Y, Chen Y, White JG, Zhang C, Simon DI, Wu C, Li Z, Huo Y. Platelet I?B kinase-? deficiency increases mouse arterial neointima formation via delayed glycoprotein Ib? shedding. Arterioscler Thromb Vasc Biol. 2013;33:241-248. doi: 10.1161/ATVBAHA.112.300781.
46. Otterdal K, Pedersen TM, Solum NO. Release of soluble CD40 ligand after platelet activation: studies on the solubilization phase. Thromb Res. 2004;114:167-177. doi: 10.1016/j.thromres.2004.05.007.